Arcus Biosciences (RCUS) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$24.41
+2.4% on the day
+61.0% over 12 months
52-week range $14.60 – $31.57
Share price and insider trades
RCUS closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$13.6M
Insiders buying0
Insiders selling7
Arcus Biosciences insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 7 sold $13.6M of RCUS stock on the open market.
Get emailed when insiders cluster-buy stocks like RCUS
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
RCUS insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $2.1M | 4 |
| Q2 2026 | — | 0 | $1.1M | 6 |
| Q1 2026 | — | 0 | $681K | 3 |
| Q4 2025 | — | 0 | $10.4M | 31 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Arcus Biosciences, Inc. insiders reported open-market purchases totaling $0, while 7 insiders reported sales totaling $13.6M. 44 of 44 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 24SEC | Alexander AzoyChief Accounting Officer | Sell Plan | 2,82739,581 held (−7%) | $30.00 | $85K | -18.6% | — |
| Jul 13SEC | Juan C. JaenPresident | Sell Plan | 48,502842,307 held (−5%) | $30.05 | $1.5M | -18.8% | — |
| Jul 13SEC | Juan C. JaenPresident | Sell Plan | 19,799822,508 held (−2%) | $28.61 | $566K | -14.7% | — |
| Jul 13SEC | Juan C. JaenPresident | Sell Plan | 268822,240 held (−0%) | $29.40 | $8K | -17.0% | — |
| Jun 24SEC | Juan C. JaenPresident | Sell Plan | 14,067898,937 held (−2%) | $27.69 | $390K | -11.8% | — |
| Jun 24SEC | Juan C. JaenPresident | Sell Plan | 9,236913,004 held (−1%) | $27.03 | $250K | -9.7% | — |
| Jun 24SEC | Juan C. JaenPresident | Sell Plan | 6,431890,809 held (−1%) | $29.66 | $191K | -17.7% | — |
| Jun 24SEC | Juan C. JaenPresident | Sell Plan | 1,697897,240 held (−0%) | $28.06 | $48K | -13.0% | — |
| Jun 1SEC | Alexander AzoyChief Accounting Officer | Sell Plan | 2,56239,581 held (−6%) | $25.77 | $66K | -5.3% | — |
| May 12SEC | Ii Robert C. GoeltzCFO | Sell Plan | 7,76384,161 held (−8%) | $25.63 | $199K | -4.8% | — |
| Jan 7SEC | Juan C. JaenPresident | Sell Plan | 29,670924,393 held (−3%) | $21.34 | $633K | +14.4% | — |
| Jan 7SEC | Juan C. JaenPresident | Sell Plan | 2,053922,340 held (−0%) | $22.34 | $46K | +9.3% | — |
| Jan 7SEC | Juan C. JaenPresident | Sell Plan | 100922,240 held (−0%) | $23.20 | $2K | +5.2% | — |
| Jan 2SEC | Ii Robert C. GoeltzCFO | Sell Plan | 6,55267,924 held (−9%) | $23.38 | $153K | +4.4% | — |
| Dec 18SEC | Terry J RosenCEO | Sell Plan | 28,9472,220,553 held (−1%) | $21.88 | $633K | +11.6% | — |
| Dec 18SEC | Terry J RosenCEO | Sell Plan | 25,7442,194,809 held (−1%) | $22.16 | $570K | +10.2% | — |
| Dec 18SEC | Jennifer JarrettCOO | Sell Plan | 11,225203,007 held (−5%) | $21.88 | $246K | +11.6% | — |
| Dec 18SEC | Juan C. JaenPresident | Sell Plan | 11,225355,995 held (−3%) | $21.88 | $246K | +11.6% | — |
| Dec 18SEC | Jennifer JarrettCOO | Sell Plan | 9,983193,024 held (−5%) | $22.16 | $221K | +10.2% | — |
| Dec 18SEC | Juan C. JaenPresident | Sell Plan | 9,983346,012 held (−3%) | $22.16 | $221K | +10.2% | — |
| Dec 18SEC | Carolyn C. TangGeneral Counsel | Sell Plan | 7,658131,544 held (−6%) | $21.88 | $168K | +11.6% | — |
| Dec 18SEC | Carolyn C. TangGeneral Counsel | Sell Plan | 6,810124,734 held (−5%) | $22.16 | $151K | +10.2% | — |
| Dec 18SEC | Ii Robert C. GoeltzCFO | Sell Plan | 6,70280,436 held (−8%) | $21.88 | $147K | +11.6% | — |
| Dec 18SEC | Ii Robert C. GoeltzCFO | Sell Plan | 5,96074,476 held (−7%) | $22.16 | $132K | +10.2% | — |
| Dec 18SEC | Richard MarkusChief Medical Officer | Sell Plan | 5,05270,141 held (−7%) | $21.88 | $111K | +11.6% | — |
| Dec 18SEC | Richard MarkusChief Medical Officer | Sell Plan | 4,49465,647 held (−6%) | $22.16 | $100K | +10.2% | — |
| Dec 18SEC | Alexander AzoyChief Accounting Officer | Sell Plan | 4,34318,531 held (−19%) | $22.25 | $97K | +9.7% | — |
| Dec 18SEC | Alexander AzoyChief Accounting Officer | Sell Plan | 2,37624,987 held (−9%) | $21.88 | $52K | +11.6% | — |
| Dec 18SEC | Alexander AzoyChief Accounting Officer | Sell Plan | 2,11322,874 held (−8%) | $22.16 | $47K | +10.2% | — |
| Dec 5SEC | Juan C. JaenPresident | Sell Plan | 82,997954,063 held (−8%) | $24.71 | $2.1M | -1.2% | — |
| Dec 1SEC | Alexander AzoyChief Accounting Officer | Sell Plan | 1,90027,363 held (−6%) | $26.00 | $49K | -6.1% | — |
| Nov 26SEC | Ii Robert C. GoeltzCFO | Sell Plan | 5,00087,138 held (−5%) | $25.00 | $125K | -2.4% | — |
| Nov 19SEC | Juan C. JaenPresident | Sell Plan | 37,1141,049,946 held (−3%) | $20.23 | $751K | +20.7% | — |
| Nov 19SEC | Juan C. JaenPresident | Sell Plan | 7,8361,042,110 held (−1%) | $20.71 | $162K | +17.9% | — |
| Nov 19SEC | Juan C. JaenPresident | Sell Plan | 5,0501,037,060 held (−0%) | $19.75 | $100K | +23.6% | — |
| Nov 12SEC | Jennifer JarrettCOO | Sell Plan | 50,291214,232 held (−19%) | $18.97 | $954K | +28.7% | — |
| Nov 3SEC | Juan C. JaenPresident | Sell Plan | 4,3141,087,060 held (−0%) | $20.32 | $88K | +20.1% | — |
| Oct 30SEC | Juan C. JaenPresident | Sell Plan | 47,6751,121,539 held (−4%) | $20.49 | $977K | +19.1% | — |
| Oct 30SEC | Juan C. JaenPresident | Sell Plan | 29,3651,092,174 held (−3%) | $21.53 | $632K | +13.4% | — |
| Oct 30SEC | Juan C. JaenPresident | Sell Plan | 19,0191,169,214 held (−2%) | $20.19 | $384K | +20.9% | — |
| Oct 30SEC | Juan C. JaenPresident | Sell Plan | 8001,091,374 held (−0%) | $22.04 | $18K | +10.8% | — |
| Oct 29SEC | Ii Robert C. GoeltzCFO | Sell Plan | 5,00092,138 held (−5%) | $20.00 | $100K | +22.0% | — |
| Oct 8SEC | Jennifer JarrettCOO | Sell Plan | 37,792214,232 held (−15%) | $15.05 | $569K | +62.2% | — |
| Oct 8SEC | Jennifer JarrettCOO | Sell Plan | 12,500214,232 held (−6%) | $14.54 | $182K | +67.9% | — |
Insiders at Arcus Biosciences, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Juan C. JaenPresident | — | $9.2M | Jul 13, 2026 | — |
| Jennifer JarrettCOO | — | $2.2M | Dec 18, 2025 | — |
| Terry J RosenCEO | — | $1.2M | Dec 18, 2025 | — |
| Ii Robert C. GoeltzCFO | — | $856K | May 12, 2026 | — |
| Alexander AzoyChief Accounting Officer | — | $396K | Aug 24, 2026 | — |
| Carolyn C. TangGeneral Counsel | — | $318K | Dec 18, 2025 | — |
| Richard MarkusChief Medical Officer | — | $210K | Dec 18, 2025 | — |
RCUS stock: common questions
Are Arcus Biosciences, Inc. insiders buying RCUS stock?
In the past 12 months, 0 insiders reported open-market purchases of RCUS worth $0.
Are Arcus Biosciences, Inc. insiders selling RCUS stock?
7 insiders reported sales worth $13.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is RCUS's 52-week range?
Over the past year RCUS has traded between $14.60 and $31.57. It last closed at $24.41 on Oct 9, 2026.